Chemical Structure : XL-647
CAS No.: 781613-23-8
货号: PC-43486Not For Human Use, Lab Use Only.
XL-647 (Tesevatinib, EXEL-7647, KD-019) is a novel spectrum-selective kinase inhibitor that potently inhibits the EGFR, ErbB2, KDR and EphB4 with IC50 of 0.3, 16, 1.5 and 1.4 nM, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥1280 | In stock | |
5 mg | ¥2180 | In stock | |
10 mg | ¥3580 | In stock | |
25 mg | Get quote | ||
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
XL-647 (Tesevatinib, EXEL-7647, KD-019) is a novel spectrum-selective kinase inhibitor that potently inhibits the EGFR, ErbB2, KDR and EphB4 with IC50 of 0.3, 16, 1.5 and 1.4 nM, respectively.
XL-647 shows no inhibition on IGF1R and InsR, also is inactive against a panel of 55 serine-threonine kinases, including CDKs, stress-activated protein kinases, and PKC isoform.
XL-647 inhibits WT and mutant EGFR phosphorylation in cells with IC50 of 5 and 74 nM, inhibits mutant EGFR resistant to gefitinib and erlotinib, inhibits cellular proliferation and EGFR pathway activation in the erlotinib-resistant H1975 cell line that harbors double mutation L858R/T790M.
XL-647 inhibits H1975 xenograft tumors and reduces both tumor EGFR signaling and tumor vessel density in vivo.
分子量 | 491.39 | |
分子式 | C24H25Cl2FN4O2 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 30 mg/mL |
|
Chemical Name/SMILES |
4-Quinazolinamine, N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[[(3aα,5β,6aα)-octahydro-2-methylcyclopenta[c]pyrrol-5-yl]methoxy]- |
1. Pietanza MC, et al. J Thorac Oncol. 2012 Jan;7(1):219-26.
2. Gendreau SB, et al. Clin Cancer Res. 2007 Jun 15;13(12):3713-23.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright